Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vectibix with chemoradiation in anal squamous cell carcinoma
NCT01285778Phase 2Completed
- Sponsor
- GEMCAD
- Start
- Oct 2010
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in anal squamous cell carcinoma (SCCA), sponsored by GEMCAD. Started Oct 2010; status: completed.
02
Drugs
panitumumab
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT01285778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285778.